Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RQ5Z
|
|||
| Drug Name |
Shan 6
|
|||
| Indication | Pertussis [ICD-11: 1C12] | Phase 3 | [1] | |
| Diphtheria [ICD-11: 1C17] | Phase 2 | [2] | ||
| Haemophilus influenza [ICD-11: 1G40; ICD-10: A49.2] | Phase 2 | [2] | ||
| Hepatitis B virus infection [ICD-11: 1E51.0; ICD-10: B18.1] | Phase 2 | [2] | ||
| Poliomyelitis [ICD-11: 1C81] | Phase 2 | [2] | ||
| Poliovirus infection [ICD-11: 1C8Y] | Phase 2 | [2] | ||
| Tetanus [ICD-11: 1C13; ICD-10: A30-A49, A35] | Phase 2 | [2] | ||
| Company |
Sanofi Pasteur Swiftwater, PA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04429295) Study of DTwP-HepB-Hib-IPV (SHAN6) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.